Efficacy of BIS Monitoring in Deep Hypnotic State
Launched by INDONESIA UNIVERSITY · Dec 10, 2023
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a device called the BIS monitor, which helps doctors track how deeply a patient is under anesthesia during surgery. The goal is to see if using this monitor can improve the care of patients undergoing neurosurgery, particularly in terms of their recovery and any confusion or delirium they might experience afterward.
To participate in the study, patients need to be between 30 and 60 years old and fit a specific health status. They should be having surgery that lasts longer than three hours under general anesthesia. However, certain patients are not eligible, such as those who are receiving specific medications or have serious health issues affecting their blood pressure, electrolytes, liver, or kidneys. If someone joins the study, they can expect close monitoring during their surgery and will contribute to important research that could help improve outcomes for future patients. The trial is not yet recruiting participants, but it aims to gather valuable information about the effects of anesthesia on recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 30-60 years with an ASA tolerance of 1-2 who will undergo general anesthesia techniques
- • Operation duration \> 3 hours
- • The patient agrees to take part in the study.
- Exclusion Criteria:
- • Continuous intraoperative use of ketamine, magnesium sulfate, dexmedetomidine, lidocaine agents
- • Massive bleeding that causes hemodynamic disturbances
- • Severe electrolyte disturbances
- • Severe liver or kidney function disorders
- • The patient was decided not to extubate in the operating room
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported